Mooy Pharma SRL
1.2 FTEThe score of Mooy Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +155 % Total assets +56 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mooy Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 145,608 € | ||||
| Equity | 365,338 € | ||||
| Cash | 183,984 € | ||||
| EBITDA | 270,466 € | ||||
| Total assets | €1.74m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jul 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 17 Aug 2022
Mooy Pharma's financial analysis
- Solvency21.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mooy Pharma
Mooy Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0846.742.494
- VAT number
- BE0846742494
- Peppol
- Registered · 0208:0846742494 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Jun 2012
- Registered office
- 8630 Veurne
- Size
- Micro · 1.2 FTE
- Latest accounts
- 2025 · filed on 24 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Mooy Pharma (SRL) has been based in Veurne since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 145,608 € and equity of 365,338 €; its revenue is not published. With 1.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 21.0%, below the median of its sector (44.2%).
Companies similar to Mooy Pharma
Companies in the same business, of comparable size and area, outside its group.
- Inge Thoelen Retail sale of pharmaceutical products Landen · balance sheet €1.74m
- Apelec Retail sale of pharmaceutical products Zemst · balance sheet €1.74m
- Apotheek Hasseltsepoort Retail sale of pharmaceutical products Diest · balance sheet €1.74m
- Den Baksteen Retail sale of pharmaceutical products Asse · balance sheet €1.73m
- Pharmacie Charue Retail sale of pharmaceutical products Fleurus · balance sheet €1.76m
- Hampharma Retail sale of pharmaceutical products Tessenderlo-Ham · balance sheet €1.75m
- Pharma City 2 Retail sale of pharmaceutical products Brussels · balance sheet €1.72m
- Selvais Retail sale of pharmaceutical products Bastogne · balance sheet €1.75m
Frequently asked questions about Mooy Pharma
What is the revenue of Mooy Pharma?
Mooy Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mooy Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0846742494 for Mooy Pharma, if the company is VAT-registered. Its company number (CBE) is 0846.742.494.
Where is the registered office of Mooy Pharma?
According to the CBE register, the registered office of Mooy Pharma is in 8630 Veurne.
What is the equity of Mooy Pharma?
At the close of the 2025 financial year, the equity of Mooy Pharma amounts to 365,338 €, a solvency of 21.0% of total assets.
How many people work at Mooy Pharma?
1.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Mooy Pharma?
The register lists 1 active mandates at Mooy Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mooy Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →